ABSTRACT OBJECTIVES This study sought to investigate the association between the extent, location, and pattern of late gadolinium enhancement (LGE) and outcome in a large dilated cardiomyopathy (DCM) cohort.
LGE that provides the optimal mode of risk stratification will help guide the use of this technique in clinical practice.
METHODS
Consecutive patients with DCM referred to our unit between 2000 and 2011 were screened for a registry.
All participants provided written informed consent and the study was approved by the National Research Ethics Service. The diagnosis of DCM was confirmed using the World Health Organization/International Society and Federation of Cardiology definition, based on reduced LVEF and elevated LV end-diastolic volume indexed to body surface area (BSA) (LVEDVi), compared to published age-and sex-specific reference values (5) . Exclusion criteria ( Figure 1 ) included ischemic heart disease, defined as a stenosis of >50% in a major coronary artery or evidence of inducible ischemia on functional testing; evidence of acute myocarditis, or ongoing inflammatory myocardial disease; hypertrophic cardiomyopathy; arrhythmogenic right ventricular cardiomyopathy; significant valve disease; and infiltrative disease. In keeping with guidelines (6, 7) , an ischemic etiology was considered in all patients and ruled out as follows: All those with infarct patterns of LGE were excluded.
Additionally, 681 (77.9%) underwent coronary angiography and 63 (7.2%) perfusion imaging or stress echocardiography without provocation of ischemia.
All of the remaining patients (n ¼ 130) were free of angina and considered to have a low risk of ischemic heart disease by their attending cardiologists; the majority (n ¼ 82) were 40 years of age or younger. In the absence of a class 1 indication, coronary angiography was not performed (6, 7) . None of these patients underwent coronary revascularization or suffered an acute coronary syndrome during follow-up. The final cohort included 682 from previous studies, all of whom underwent extended follow-up for this study (1, 4) .
CMR was performed on a 1.5-T system (Sonata/ Avanto, Siemens, Erlangen, Germany) using a standardized protocol (4). Late gadolinium imaging was 
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RESULTS
The final cohort comprised 874 patients, of whom 588 (67.3%) were men, the median LVEF was 39% (interquartile range: 29% to 50%), and nonischemic LGE was present in 300 (34.3%). Baseline characteristics are presented in Table 1 . Patients with LGE were older LGE was present only in the septum in 142 (16.2%) cases, only in the LV free-wall in 42 (4.8%), and in both locations in 116 (13.3%) ( Figure 2 ).
LGE was Table 1 ).
Additionally, there was 86.7% agreement in categorizing the LGE extent within 3 groups (>0 and <2.55%, $2.55% and <5.10%, and $5.10%) (Kappa coefficient: 0.80) (Supplemental Table 2 ). CI: 1.30 to 2.52; p < 0.001) (Supplemental Table 3 ).
The estimated HRs were similar after additionally adjusting for RVEF, NYHA class, LVEDVi, LV mass index, and LAVi as part of a sensitivity analysis (Supplemental Tables 3 and 4 , Supplemental Figure 3 ).
Extent of LGE. Estimated adjusted HRs for patients
with LGE extents of 0 to 2.55%, 2.55% to 5.10%, and (Figures 3 and 4 LGE to the baseline multivariable models without
LGE improved the C-statistic for the prediction of allcause mortality (Supplemental Table 3 ).
SCD AND ABORTED SCD. Overall, 84 patients (9.6%) suffered SCD or aborted SCD, including 55 patients (18.3%) with LGE and 29 (5.1%) without (HR: 4.12; 95% CI: 2.64 to 6.45; p < 0.001) (Supplemental Figure 5A) .
Following adjustment for LVEF, age, and sex, LGE was associated with SCD and aborted SCD (HR: 3.96; 95% CI: 2.41 to 6.52; p < 0.001) (Supplemental Table 5 ). The estimated HRs were similar following adjustment for additional covariates as part of a sensitivity analysis (Supplemental Tables 5 and 6 Figure 5D ). Overall, the model with the smallest AIC that best predicted the SCD endpoint was based on the presence and location of LGE within the septum, the freewall, or in both locations ( Table 3) . This was superior to models based on extent and pattern of LGE. Adding the presence of any LGE and the presence of LGE by location to the baseline multivariable models without
LGE improved the C-statistic for the prediction of the SCD composite (Supplemental Table 5 ).
DISCUSSION
This is the largest study to date to examine the association between the extent, location, and pattern of
LGE and outcome in a large, well-phenotyped DCM cohort. We show the superiority of models based on the presence and location of LGE for the prediction of all-cause mortality and SCD events over those based on LGE extent and pattern ( Figure 5 ). Our data also establish a nonlinear association between LGE extent and outcome, with a large increase in risk with small degrees of LGE and less marked increases with greater extents thereafter ( Figure 5 ). The increase in risk with small amounts of LGE was most marked for SCD events (Figure 3) .
Previous studies have shown that nonischemic LGE
is associated with an increased risk of death and arrhythmic events (1, 11) . It has been proposed that
LGE-CMR may be able to improve the selection of patients who benefit from ICD implantation (12) .
However, up until now there has been a paucity of data examining the relationship between LGE extent, location, pattern, and specific outcomes.
Our data suggest that measures based on LGE location are better than those based on extent for risk prediction. We show that patients with septal LGE were at highest risk of death whereas those with freewall LGE were at similar risk to those without LGE.
Accordingly, a model based on the presence of septal
LGE best predicted all-cause mortality. Whereas septal LGE was also associated with increased SCD events, the greatest risk was seen with concomitant septal and free-wall LGE. A model accounting for the greater risk associated with concomitant LGE in the septum and free-wall was most effective for SCD.
Additionally, sub-epicardial or multiple patterns of
LGE were associated with a high-risk of SCD events.
These data add important new information on how to best to use LGE-CMR in risk stratification, an area of unmet need (12, 13) . Similar to our results, septal LGE has been associated with worse prognosis in myocarditis (14) . The variation in risk based on location may be explained by differences in etiological substrate, scar microstructure, and geographical effects. Idiopathic DCM is most commonly associated with septal mid-wall LGE whereas a previous episode of myocarditis, the cause of a third of DCM, is often associated with free-wall LGE (%) Halliday et al.
LGE ( We also show a nonlinear relationship between
LGE extent and outcome, such that small degrees of fibrosis are associated with a large increase in risk, particularly with regards to SCD events. This may be explained by the multifactorial disease process.
Replacement fibrosis is 1 of several processes contributing to ventricular arrhythmogenesis (3). It is likely that the synergistic presence of multiple features leads to ventricular arrhythmia rather than 1 factor in a linear dose-dependent manner. In addition, it appears that risk is influenced by fibrosis microstructure and heterogeneity, not simply mass.
Areas of scar with the greatest heterogeneity will cause the largest variation in conduction velocities and the greatest chance of creating re-entrant arrhythmia. Computational scar modeling offers the potential to provide important insights (19) . Hazard Ratio LGE" is compared to "no-Septal LGE." Abbreviations as in Figure 3 .
Halliday et al.
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LGE location Relevance to Mortality Risk Relevance to SCD Risk Our study of dilated cardiomyopathy patients shows a nonlinear relationship between late gadolinium enhancement (LGE) extent and all-cause mortality and sudden cardiac death (SCD) events with a large increase in risk with small degrees of LGE. We show the superiority of models based on the location of
LGE for the prediction of these end-points. DCM ¼ dilated cardiomyopathy; other abbreviations as in Figure 3 . smaller number of patients in sub-groups such as those with focal or sub-epicardial LGE does, however, limit the interpretation of this specific data.
We recognize that not all arrhythmias resulting in appropriate shocks may have resulted in SCD if untreated. However, we have selected the most robust definition available, excluding antitachycardia pacing (8) . We acknowledge that the use of different contrast agents has the potential to impact LGE quantification.
However, there was no difference in the quantity, pattern, or location of LGE for patients scanned with gadobutrol compared to gadopentetate dimeglumine.
In addition, the associations between LGE and outcome remain similar when patients are divided based on contrast agent and there was no difference in the estimated effect of LGE on outcome between groups (Supplemental Table 7 ). The impact of the use of different contrast agents on the results of the study, therefore, appears to be minimal.
Parametric mapping was not available at the outset of the current study and was therefore not included in the analysis. This technique has the advantage of identifying diffuse myocardial changes which LGE imaging may not detect. Previous work has shown associations between native T1 values and mortality and heart failure outcomes in DCM (21) . Given the possible role of diffuse fibrosis in arrhythmia generation and heart failure, parametric mapping offers hope in the identification of those at risk of adverse outcomes. We eagerly await further data examining the incremental value of parametric mapping. Our data suggest the need to examine the incremental value of this technique in addition to the presence of septal LGE.
CONCLUSIONS
We show a large increase in all-cause mortality and 
